- Conditions
- Autoimmune Pulmonary Alveolar Proteinosis
- Interventions
- Molgramostim nebulizer solution
- Drug
- Lead sponsor
- Savara Inc.
- Industry
- Eligibility
- 18 Years and older
- U.S. locations
- 9
- States / cities
- Los Angeles, California • Gainesville, Florida • Baltimore, Maryland + 6 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–48
of 50
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Respiratory Distress Syndrome (Neonatal), Surfactant Deficiency Syndrome Neonatal
- Interventions
- Video Laryngoscopy, Direct Laryngoscopy
- Procedure
- Lead sponsor
- University of Texas Southwestern Medical Center
- Other
- Eligibility
- 0 Hours to 3 Days
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Prematurity, Respiratory Distress Syndrome, Patent Ductus Arteriosus
- Interventions
- Survanta (beractant), Curosurf (poractant)
- Drug
- Lead sponsor
- Alan Fujii
- Other
- Eligibility
- Up to 8 Hours
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2009
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Respiratory Distress Syndrome, Newborn, Premature Birth
- Interventions
- Poractant Alfa
- Drug
- Lead sponsor
- Endeavor Health
- Other
- Eligibility
- Up to 15 Minutes
- Enrollment
- 200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- Evanston, Illinois
- Conditions
- Infant, Newborn, Respiratory Distress Syndrome, Respiratory Insufficiency
- Interventions
- Early surfactant, Standard practice
- Drug
- Lead sponsor
- NICHD Neonatal Research Network
- Network
- Eligibility
- Up to 12 Hours
- Enrollment
- 61 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2000 – 2002
- U.S. locations
- 13
- States / cities
- Birmingham, Alabama • Palo Alto, California • New Haven, Connecticut + 10 more
- Conditions
- Respiratory Distress Syndrome, Newborn, Premature Birth, Bronchopulmonary Dysplasia
- Interventions
- Lucinactant 175 mg/kg, Lucinactant 90 mg/kg, Placebo
- Drug
- Lead sponsor
- Windtree Therapeutics
- Industry
- Eligibility
- 3 Days to 10 Days
- Enrollment
- 136 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 1
- States / cities
- Warrington, Pennsylvania
- Conditions
- Pulmonary Alveolar Proteinosis
- Interventions
- Not listed
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Other
- Eligibility
- Not listed
- Enrollment
- 500 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2030
- U.S. locations
- 1
- States / cities
- Cincinnati, Ohio
- Conditions
- Acute Respiratory Distress Syndrome
- Interventions
- CUROSURF® (poractant alfa)
- Drug
- Lead sponsor
- Chiesi Farmaceutici S.p.A.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 22 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Detroit, Michigan
- Conditions
- Respiratory Distress Syndrome, Newborn
- Interventions
- Endotracheal intubation, Laryngeal mask airway, remifentanil
- Device · Drug
- Lead sponsor
- Albany Medical College
- Other
- Eligibility
- 2 Hours to 48 Hours
- Enrollment
- 93 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2020
- U.S. locations
- 1
- States / cities
- Albany, New York
- Conditions
- Extreme Prematurity, Respiratory Distress Syndrome
- Interventions
- LISA
- Procedure
- Lead sponsor
- University of Texas Southwestern Medical Center
- Other
- Eligibility
- 5 Minutes to 20 Minutes
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2025
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Premature Lungs, Respiratory Distress Syndrome, Surfactant Deficiency Syndrome Neonatal
- Interventions
- Less Invasive Surfactant Administration LISA, Continuous Positive Airway Pressure CPAP
- Procedure
- Lead sponsor
- Sharp HealthCare
- Other
- Eligibility
- 24 Weeks to 29 Weeks
- Enrollment
- 180 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2025
- U.S. locations
- 3
- States / cities
- Irvine, California • Loma Linda, California • San Diego, California
- Conditions
- Respiratory Distress Syndrome, Newborn
- Interventions
- Surfactant administered via Laryngeal Mask Airway (LMA), standard of care (nasal CPAP and supplemental oxygen)
- Device · Other
- Lead sponsor
- University of Virginia
- Other
- Eligibility
- Up to 72 Hours
- Enrollment
- 380 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2009
- U.S. locations
- 1
- States / cities
- Charlottesville, Virginia
- Conditions
- Respiratory Distress Syndrome
- Interventions
- Nasal continuous positive airway pressure (nCPAP), Laryngeal Mask Airway (LMA) to deliver surfactant, Surfactants, Pulmonary
- Device · Drug
- Lead sponsor
- University of Minnesota
- Other
- Eligibility
- Up to 36 Hours
- Enrollment
- 103 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2015
- U.S. locations
- 7
- States / cities
- Loma Linda, California • San Diego, California • Maple Grove, Minnesota + 4 more
- Conditions
- Respiratory Distress Syndrome of Prematurity (Surfactant Dysfunction), Bronchopulmonary Dysplasia
- Interventions
- Infasurf (ONY Inc.), Sham
- Drug
- Lead sponsor
- Roberta Ballard
- Other
- Eligibility
- 7 Days to 14 Days
- Enrollment
- 85 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2012
- U.S. locations
- 9
- States / cities
- Berkeley, California • Oakland, California • San Francisco, California + 5 more
- Conditions
- Respiratory Distress Syndrome (Neonatal), Surfactant
- Interventions
- Surfactant Administration Through Laryngeal or Supraglottic Airway (SALSA), Continuous Positive Airway Pressure (CPAP)
- Procedure
- Lead sponsor
- Sharp HealthCare
- Other
- Eligibility
- 33 Weeks to 38 Weeks
- Enrollment
- 422 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2031
- U.S. locations
- 3
- States / cities
- Chula Vista, California • La Mesa, California • San Diego, California
- Conditions
- Respiratory Distress Syndrome in Premature Infant
- Interventions
- AeroFact, nCPAP
- Drug · Other
- Lead sponsor
- Aerogen Pharma Limited
- Industry
- Eligibility
- 26 Weeks to 31 Weeks
- Enrollment
- 261 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2024
- U.S. locations
- 37
- States / cities
- Little Rock, Arkansas • Berkeley, California • Orange, California + 27 more
- Conditions
- Respiratory Distress Syndrome, Newborn, Pulmonary Surfactants, Intensive Care Units, Neonatal
- Interventions
- Echography-guided Surfactant THERapy (ESTHER)
- Diagnostic Test
- Lead sponsor
- Connecticut Children's Medical Center
- Other
- Eligibility
- 0 Hours to 2 Hours
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 1
- States / cities
- Hartford, Connecticut
- Conditions
- Bronchiolitis
- Interventions
- Aerosolized Infasurf
- Combination Product
- Lead sponsor
- ONY
- Industry
- Eligibility
- 0 Months to 4 Months
- Enrollment
- 13 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Richmond, Virginia
- Conditions
- Respiratory Distress Syndrome, Newborn
- Interventions
- Neer Infrared Spectroscopy
- Device
- Lead sponsor
- Keck School of Medicine of USC
- Other
- Eligibility
- 1 Hour to 24 Hours
- Enrollment
- 50 participants
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Bronchopulmonary Dysplasia
- Interventions
- Infasurf surfactant (ONY, Inc.), Sham (No Treatment)
- Drug
- Lead sponsor
- Roberta Ballard
- Other
- Eligibility
- 7 Days to 14 Days
- Enrollment
- 511 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2016
- U.S. locations
- 21
- States / cities
- Little Rock, Arkansas • Berkeley, California • Oakland, California + 15 more
- Conditions
- Respiratory Distress Syndrome
- Interventions
- Aerosolized Calfactant, Solarys
- Drug · Device
- Lead sponsor
- ONY
- Industry
- Eligibility
- 1 Hour to 24 Hours
- Enrollment
- 477 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 22
- States / cities
- Mobile, Alabama • Phoenix, Arizona • San Diego, California + 19 more
- Conditions
- Lung Diseases, Respiratory Distress Syndrome, Newborn, Pulmonary Surfactant, Lung Diseases, Interstitial
- Interventions
- Not listed
- Lead sponsor
- Washington University School of Medicine
- Other
- Eligibility
- Up to 1 Year
- Enrollment
- 5,176 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2001 – 2024
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
- Conditions
- Infant, Newborn, Infant, Low Birth Weight, Infant, Small for Gestational Age, Infant, Premature, Bronchopulmonary Dysplasia, Continuous Positive Airway Pressure
- Interventions
- CPAP/PEEP, Standard management practices
- Device
- Lead sponsor
- NICHD Neonatal Research Network
- Network
- Eligibility
- Up to 10 Minutes
- Enrollment
- 104 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2003
- U.S. locations
- 6
- States / cities
- Birmingham, Alabama • San Diego, California • Miami, Florida + 3 more
- Conditions
- Infant, Newborn, Diseases, Other Preterm Infants, Infant, Small for Gestational Age, Premature Birth, Bronchopulmonary Dysplasia, Retinopathy of Prematurity
- Interventions
- Surfactant, Continuous Positive Airway Pressure (CPAP), Supplemental oxygen with target saturation of 85 to 89%, Supplemental oxygen with target saturation of 91 to 95%
- Drug · Device
- Lead sponsor
- NICHD Neonatal Research Network
- Network
- Eligibility
- 24 Weeks to 27 Weeks
- Enrollment
- 1,316 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2016
- U.S. locations
- 22
- States / cities
- Birmingham, Alabama • Palo Alto, California • San Diego, California + 18 more